Compugen
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical tria… Read more
Compugen (CGEN) - Total Liabilities
Latest total liabilities as of September 2025: $54.02 Million USD
Based on the latest financial reports, Compugen (CGEN) has total liabilities worth $54.02 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Compugen - Total Liabilities Trend (1999–2024)
This chart illustrates how Compugen's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Compugen Competitors by Total Liabilities
The table below lists competitors of Compugen ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
USA | $33.55 Million |
|
Beijing North Star Company Limited
PINK:BEIJF
|
USA | $34.91 Billion |
|
Omai Gold Mines Corp
OTCQB:OMGGF
|
USA | $2.05 Million |
|
Wenzhou Yuanfei Pet Toy Products Co. Ltd. A
SHE:001222
|
China | CN¥227.19 Million |
|
CWB Automotive Electronics Co Ltd
SHG:605005
|
China | CN¥505.17 Million |
|
Eczacibasi Yatirim Holding Ortakligi AS
IS:ECZYT
|
Turkey | TL573.72 Million |
|
China General Plastics Corp
TW:1305
|
Taiwan | NT$9.19 Billion |
|
China MeiDong Auto Holdings Limited
PINK:CMEIF
|
USA | $4.96 Billion |
Liability Composition Analysis (1999–2024)
This chart breaks down Compugen's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Compugen's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Compugen (1999–2024)
The table below shows the annual total liabilities of Compugen from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $60.08 Million | +7.72% |
| 2023-12-31 | $55.77 Million | +238.11% |
| 2022-12-31 | $16.50 Million | -35.23% |
| 2021-12-31 | $25.47 Million | +37.42% |
| 2020-12-31 | $18.53 Million | +20.02% |
| 2019-12-31 | $15.44 Million | -3.11% |
| 2018-12-31 | $15.94 Million | +68.66% |
| 2017-12-31 | $9.45 Million | +24.00% |
| 2016-12-31 | $7.62 Million | -19.02% |
| 2015-12-31 | $9.41 Million | +6.09% |
| 2014-12-31 | $8.87 Million | -64.27% |
| 2013-12-31 | $24.82 Million | +120.90% |
| 2012-12-31 | $11.24 Million | +18.28% |
| 2011-12-31 | $9.50 Million | +16.24% |
| 2010-12-31 | $8.17 Million | +193.25% |
| 2009-12-31 | $2.79 Million | -34.28% |
| 2008-12-31 | $4.24 Million | -3.20% |
| 2007-12-31 | $4.38 Million | -14.40% |
| 2006-12-31 | $5.12 Million | -12.63% |
| 2005-12-31 | $5.86 Million | +1.23% |
| 2004-12-31 | $5.79 Million | -25.02% |
| 2003-12-31 | $7.72 Million | -7.86% |
| 2002-12-31 | $8.38 Million | +15.90% |
| 2001-12-31 | $7.23 Million | +34.78% |
| 2000-12-31 | $5.36 Million | +96.34% |
| 1999-12-31 | $2.73 Million | -- |